Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Shinsuke Yamanda"'
Autor:
Soichiro Minami, Yosuke Kawashima, Yasuhiko Munakata, Masahiro Matsuno, Shuichiro Hara, Yusuke Yamazaki, Tsuyoshi Doman, Shin Saito, Tetsuo Odaka, Takahiro Ogasawara, Hisashi Shimizu, Jun Sugisaka, Tomoiki Aiba, Yukihiro Toi, Shinsuke Yamanda, Yuichiro Kimura, Shunichi Sugawara
Publikováno v:
Cancer Reports, Vol 7, Iss 7, Pp n/a-n/a (2024)
ABSTRACT Background The expansion of preoperative immunochemotherapy has led to an increase in the number of patients with lung cancer receiving immune checkpoint inhibitors (ICIs). Therefore, oncologists should manage a variety of immune‐related a
Externí odkaz:
https://doaj.org/article/5543c1d253ce41568754fb0610f4abf2
Autor:
Jun Sugisaka, Yukihiro Toi, Yosuke Kawashima, Yutaka Domeki, Tomoiki Aiba, Sachiko Kawana, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Shunichi Sugawara
Publikováno v:
Thoracic Cancer, Vol 14, Iss 31, Pp 3140-3146 (2023)
Abstract Background There is no well‐established late‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC). Therefore, we retrospectively determined the efficacy and safety of platinum rechallenge with paclitaxel‐carbopl
Externí odkaz:
https://doaj.org/article/84ab70da4dee413d96eac46f9b6875a9
Autor:
Yosuke Murakami, Yosuke Kawashima, Shinji Chiba, Shuichiro Hara, Yusuke Yamazaki, Tsuyoshi Doman, Shin Saito, Tetsuo Odaka, Takahiro Ogasawara, Hisashi Shimizu, Jun Sugisaka, Tomoiki Aiba, Yukihiro Toi, Shinsuke Yamanda, Yuichiro Kimura, Shunichi Sugawara
Publikováno v:
Cancer Reports, Vol 7, Iss 2, Pp n/a-n/a (2024)
Abstract Background Anaplastic lymphoma kinase (ALK)‐positive lung cancer has a better long‐term prognosis with ALK‐inhibitor than other lung cancers. However, resistance to ALK‐inhibitors and the control of metastases in the central nervous
Externí odkaz:
https://doaj.org/article/6a69036d500340d1912700c168116d18
Autor:
Kana Ono, Hirotaka Ono, Yukihiro Toi, Jun Sugisaka, Mari Aso, Ryohei Saito, Sachiko Kawana, Tomoiki Aiba, Tetsuo Odaka, Suguru Matsuda, Shin Saito, Akane Narumi, Takahiro Ogasawara, Hisashi Shimizu, Yutaka Domeki, Keisuke Terayama, Yosuke Kawashima, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Yoshihiro Honda, Shunichi Sugawara
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4796-4804 (2021)
Abstract Background The association between the development of checkpoint inhibitor pneumonitis (CIP) with tumor response and survival has remained unclear so far. The aim of the present study was to evaluate the association between CIP and the clini
Externí odkaz:
https://doaj.org/article/efc9d6dd8dd248d5880341fb0395fe7c
Autor:
Tomoiki Aiba, Chieko Hattori, Jun Sugisaka, Hisashi Shimizu, Hirotaka Ono, Yutaka Domeki, Ryohei Saito, Sachiko Kawana, Yosuke Kawashima, Keisuke Terayama, Yukihiro Toi, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Yutaka Suzuki, Atsushi Niida, Shunichi Sugawara
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0260500 (2021)
Although anti-PD-1/PD-L1 monotherapy has achieved clinical success in non-small cell lung cancer (NSCLC), definitive predictive biomarkers remain to be elucidated. In this study, we performed whole-transcriptome sequencing of pretreatment tumor tissu
Externí odkaz:
https://doaj.org/article/ff8d011cd2ee41c8b003de2f9220edcd
Autor:
Masanori Asada, Satoru Ebihara, Shinsuke Yamanda, Kaijun Niu, Tatsuma Okazaki, Ichiro Sora, Hiroyuki Arai
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 11, Iss 4, Pp 408-417 (2009)
The effects of serotonin (5-HT) on tumor growth are inconsistent. We investigated whether a decreased level of 5-HT affected tumor growth using 5-HT transporter knockout (5-HTT-/-) mice, which showed 5-HT depletion. When cancer cells were injected su
Externí odkaz:
https://doaj.org/article/c975f54a70574ccea4ec9b37ece405af
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 10, Iss 9, Pp 932-939 (2008)
Erythropoietin (Epo), a known hematopoietic growth factor, has been reported to promote tumor growth and angiogenesis in Epo receptor (EpoR)–positive tumors, but its effects on EpoR-negative tumors have not been clearly shown. Here, we show that Ep
Externí odkaz:
https://doaj.org/article/5d3820adb5224db0988f5d2931714960
Autor:
Manabu Ono, Seiichi Kobayashi, Hanagama Masakazu, Masatsugu Ishida, Hikari Sato, Koji Okutomo, Yusuke Shirai, Kodai Takahashi, Mitsuhiro Yamada, Naoya Fujino, Shinsuke Yamanda, Masaru Yanai
Publikováno v:
Medicine; 7/12/2024, Vol. 103 Issue 28, p1-6, 6p
Autor:
Mari Aso, Shunichi Sugawara, Sachiko Kawana, Tetsuo Odaka, Shinsuke Yamanda, Yukihiro Toi, Suguru Matsuda, Yoshihiro Honda, Hisashi Shimizu, Tomoiki Aiba, Ryohei Saito, Takahiro Ogasawara, Atsushi Nakamura, Akane Narumi, Hirotaka Ono, Yutaka Domeki, Keisuke Terayama, Shin Saito, Jun Sugisaka, Yosuke Kawashima, Kana Ono, Yuichiro Kimura
Publikováno v:
Cancer Medicine, Vol 10, Iss 14, Pp 4796-4804 (2021)
Cancer Medicine
Cancer Medicine
Background The association between the development of checkpoint inhibitor pneumonitis (CIP) with tumor response and survival has remained unclear so far. The aim of the present study was to evaluate the association between CIP and the clinical effic
Autor:
Masatsugu Ishida, Hikari Sato, Masaru Yanai, Masakazu Hanagama, Shinsuke Yamanda, Manabu Ono, Seiichi Kobayashi
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 15:2923-2929
Purpose Asthma-COPD overlap (ACO) has been reported as an association with a lower quality of life, frequent exacerbations, and higher mortality than those with COPD alone. However, clinical characteristics and outcomes of ACO remain controversial. P